Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of CRLF2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ti,IHC-P |
More info about CRLF2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB13267 |
| Product name: | CRLF2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of CRLF2. |
| Gene id: | 64109 |
| Gene name: | CRLF2 |
| Gene alias: | CRL2|CRLF2Y|TSLPR |
| Gene description: | cytokine receptor-like factor 2 |
| Immunogen: | A synthetic peptide corresponding to internal region 19 amino acids of human CRLF2. |
| Protein accession: | Q9HC73 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.5-1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.02% sodium azide) |
| Storage instruction: | Store at 4°C for three months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Immunohistochemistry of CRLF2 in human liver tissue with CRLF2 polyclonal antibody (Cat # PAB13267) at 5 ug/mL . |
| Applications: | WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, Farr AG. J Immunol. 1999 Jan 15;162(2):677-83. |